Nursen BELET, Mustafa Yavuz KOKER, Mehmet Halil CELİKSOY, Alisan YİLDİRAN, Gulnar SENSOY, Meltem CEYHAN

Chronic granulomatous disease; Three different clinical presentation

Chronic granulomatous disease is an inherited disorder of nicotinamide-adenine dinucleotide phosphate oxidase and results in a defect in intracellular killing of ingested microorganisms characterized by recurrent life threatening bacterial and fungal infections. The disease is classified by mutations in specific subunits of the NADPH oxidase enzyme. There are one X-linked and fourautosomal recessive forms of disease. The organisms cultured from lesion of patients with chronic granulomatous disease are generally catalase-producing including Staphylococci, Escherichia coli, Serratia; or fungi such as Aspergillus species. Recurrent or serious infections usually lead to diagnosis of disease in early childhood. We report three male patients who were diagnosed 5, 10, 13 years old, respectively and showed different clinical presentation.

PDF

___

Stein S, Siler U, Ott MG, Seger R, Grez M. Gene therapy for chronic granulomatous disease. Curr Opin Mol Ther 2006;8(5):415-22.
Gungor T, Halter J, Klink A, Junge S, Stumpe KD, Seger R, et al. Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation 2005;79(11):1596-606.
Seger RA. Chronic granulomatous disease: recent advances in pathophysiology and treatment. Neth J Med 2010;68(11):334-40.
Roos D, Kuijpers TW, Curnette JT. Chronic granulamatous disease. In: Ochs HD, Smith CIE, Puck JM, editors. Primary immunodefiency diseases. A molecular and genetic approach. 2th ed. New York: Oxford University Press; 2007.p.527-49.
Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol 2013;132(5):1156-63.
Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, Krishnaswamy G. Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin Mol Allergy 2011;9;31(1):10.
Lekstrom-Himes JA, Gallin JI. Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med 2000;343(23):1703-14.
Filiz S, Kocacık Uygun DF, Yeğin O. Kronik granülomatöz hastalık. Turk J Immunol 2013;1(1):22-31.
Köker MY, Sanal O, De Boer M, Tezcan I, Metin A, Ersoy F, et al. Mutations of chronic granulomatous disease in Turkish families. Eur J Clin Invest 2007;37(7):589 95.
Keleş S, Soysal A, Özdemir C, Eifan AO, Bahçeciler N, Bakır M ve ark. İnvaziv aspergilloz infeksiyonu ve hipogamaglobulinemi ile başvuran kronik granülomatözlü bir olgu. Asthma Allergy Immunol 2009;7:189-93.
Seger RA. Modern management of chronic granulomatous disease. Br J Haematol 2008;140(3):255-66.